About Stephen Baggott
Form D filings for Sus Clinicals in 2024 list Stephen Baggott as executive officer and director.
Stephen Baggott first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Stephen Baggott in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stephen Baggott works with at each company, as listed on that company's latest Form D.
Sus Clinicals, Inc. · Form D, Jan 10, 2024
GM
Geoffrey Marshall
Executive officer and director
JW
Jeffrey Weedman
Executive officer and director